| 200938-100MG |
|
97549-41-2 |
(2R,2'R)-2,2'-Bipiperidine
≥95%,-
|
100MG |
C10H20N2 |
|
|
|
| 200702-100MG |
|
139139-92-7 |
1,1'-(1R)-[1,1'-Binaphthalene]-2,2'-diylbis[1,1-dicyclohexyl]-phosphine
≥95%,-
|
100MG |
C44H56P2 |
|
|
|
| 200700-100MG |
|
121457-42-9 |
1,1'-(1S)-[1,1'-Binaphthalene]-2,2'-diylbis[1,1-dicyclohexyl]-phosphine
≥95%,-
|
100MG |
C44H56P2 |
|
|
|
| 200668-5G |
|
28163-64-6 |
(R)-β-Methyl-benzeneethanamine
≥95%,-
|
5G |
C9 H13 N |
|
|
|
| 200667-5G |
|
17596-79-1 |
(S)-β-Methyl-benzeneethanamine
≥95%,-
|
5G |
C9 H13 N |
|
|
|
| 200519-100MG |
|
852127-05-0 |
(S)-[1,1'-Binaphthalene]-2,2'-disulfonic Acid
≥95%,-
|
100MG |
C20H14O6S2 |
|
|
|
| 200518-100MG |
|
1092934-18-3 |
(R)-[1,1'-Binaphthalene]-2,2'-disulfonic Acid
≥95%,-
|
100MG |
C20H14O6S2 |
|
|
|
| 201299-1G |
|
2304895-71-2 |
|
1G |
C21H35Cl2CoN2OP |
|
|
|
| 201299-100MG |
|
2304895-71-2 |
|
100MG |
C21H35Cl2CoN2OP |
|
|
|
| 201298-1G |
|
2304895-70-1 |
2-[[Bis(1,1-dimethylethyl)phosphino]methyl]-6-[(4S)-4-(1,1- dimethylethyl)-4,5-dihydro-2-oxazolyl]-pyridine
≥95%,-
|
1G |
C21H35N2OP |
|
|
|
| 201298-100MG |
|
2304895-70-1 |
2-[[Bis(1,1-dimethylethyl)phosphino]methyl]-6-[(4S)-4-(1,1- dimethylethyl)-4,5-dihydro-2-oxazolyl]-pyridine
≥95%,-
|
100MG |
C21H35N2OP |
|
|
|
| 201297-1G |
|
1877348-67-8 |
(SP-4-2)-[N-[1-[6-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl-κN3]-2-pyridinyl-κN]ethylidene]-2,6-bis(1-methylethyl)benzenamine-κN]methyl-cobalt
≥95%,-
|
1G |
C26H36CoN3O |
|
|
|
| 201297-100MG |
|
1877348-67-8 |
(SP-4-2)-[N-[1-[6-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl-κN3]-2-pyridinyl-κN]ethylidene]-2,6-bis(1-methylethyl)benzenamine-κN]methyl-cobalt
≥95%,-
|
100MG |
C26H36CoN3O |
|
|
|
| 201296-1G |
|
1632280-01-3 |
(SP-5-14)-Dichloro[N-[1-[6-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl-κN3]-2-pyridinyl-κN]ethylidene]-2,6-bis(1-methylethyl)benzenamine-κN]-cobalt
≥97%,99%e.e.
|
1G |
C25H33Cl2CoN3O |
|
|
|
| 201296-100MG |
|
1632280-01-3 |
(SP-5-14)-Dichloro[N-[1-[6-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl-κN3]-2-pyridinyl-κN]ethylidene]-2,6-bis(1-methylethyl)benzenamine-κN]-cobalt
≥97%,99%e.e.
|
100MG |
C25H33Cl2CoN3O |
|
|
|
| 201294-1G |
|
1632280-04-6 |
[N(E)]-N-[1-[6-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-pyridinyl]ethylidene]-2,6-bis(1-methylethyl)-benzenamine
≥97%,99%e.e.
|
1G |
C25H33N3O |
|
|
|
| 201294-100MG |
|
1632280-04-6 |
[N(E)]-N-[1-[6-[(4S)-4,5-Dihydro-4-(1-methylethyl)-2-oxazolyl]-2-pyridinyl]ethylidene]-2,6-bis(1-methylethyl)-benzenamine
≥97%,99%e.e.
|
100MG |
C25H33N3O |
|
|
|
| 201295-1G |
|
1600527-17-0 |
(SP-5-13)-[6-[[Bis(1-methylethyl)phosphino-κP]methyl]-2,2'-bipyridine-κN1,κN1']dichloro-cobalt
≥97%,-
|
1G |
C17H23Cl2CoN2P |
|
|
|
| 201295-100MG |
|
1600527-17-0 |
(SP-5-13)-[6-[[Bis(1-methylethyl)phosphino-κP]methyl]-2,2'-bipyridine-κN1,κN1']dichloro-cobalt
≥97%,-
|
100MG |
C17H23Cl2CoN2P |
|
|
|
| 201293-1G |
|
1373719-22-2 |
6-[[Bis(1-methylethyl)phosphino]methyl]-2,2'-bipyridine
≥95%,-
|
1G |
C17H23N2P |
|
|
|
